Market Overview

Kindred Biosciences (NASDAQ: KIN)

7.42 +0.14 (1.85%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/16/19DowngradesNeutral8.5
6/11/19Initiates Coverage OnOverweight13.0
5/23/19Initiates Coverage OnBuy14.0
10/31/18MaintainsOverweight25.0
8/07/18MaintainsBuy16.0
8/07/18DowngradesNeutral
7/24/18Initiates Coverage OnOverweight20.0
7/23/18Initiates Coverage OnBuy30.0
11/17/17Initiates Coverage OnBuy9.5
6/16/17Initiates Coverage OnBuy10.5

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter